Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of hepatocellular carcinoma.
Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Among authors: bruix j. Hepatogastroenterology. 2002 Jan-Feb;49(43):7-11. Hepatogastroenterology. 2002. PMID: 11941987 Review.
Hepatocellular carcinoma.
Llovet JM, Burroughs A, Bruix J. Llovet JM, et al. Among authors: bruix j. Lancet. 2003 Dec 6;362(9399):1907-17. doi: 10.1016/S0140-6736(03)14964-1. Lancet. 2003. PMID: 14667750 Review.
Chemoembolization for hepatocellular carcinoma.
Bruix J, Sala M, Llovet JM. Bruix J, et al. Gastroenterology. 2004 Nov;127(5 Suppl 1):S179-88. doi: 10.1053/j.gastro.2004.09.032. Gastroenterology. 2004. PMID: 15508083 Review.
Treatment of hepatocellular carcinoma.
Forner A, Hessheimer AJ, Isabel Real M, Bruix J. Forner A, et al. Among authors: bruix j. Crit Rev Oncol Hematol. 2006 Nov;60(2):89-98. doi: 10.1016/j.critrevonc.2006.06.001. Epub 2006 Jul 24. Crit Rev Oncol Hematol. 2006. PMID: 16860993 Review.
Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials. Llovet JM, et al. Among authors: bruix j. J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. J Natl Cancer Inst. 2008. PMID: 18477802 Review.
Sorafenib in advanced hepatocellular carcinoma.
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Llovet JM, et al. Among authors: bruix j. N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857. N Engl J Med. 2008. PMID: 18650514 Free article. Clinical Trial.
381 results